ReviewMedicine2026
ST elevation in lead aVR - a marker of critical left main coronary artery stenosis: A series of case reports and literature review.
Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleLead augmented vector right (aVR) has historically been overlooked in acute coronary syndromes. ST-segment elevation (STE) in lead aVR with diffuse ST depression in multiple leads has emerged as a critical marker for left main coronary artery (LMCA) stenosis and triple-vessel disease (3VD). Recognition of this high-risk electrocardiogram (ECG) pattern is essential for timely diagnosis and improved outcomes. PATIENT CONCERNS: In this retrospective case series, 5 consecutive patients presented to the emergency department between January 2023 and June 2024 with acute chest pain or cardiac arrest. DIAGNOSES: All 5 patients exhibited ECG findings of STE in aVR (≥1 mm) with diffuse ST depressions (≥1 mm) in ≥6 leads. All underwent coronary angiography within 24 hours, which confirmed LMCA stenosis (70%-99%; mean STE in aVR: 3.0 mm). A narrative literature review was performed using PubMed/MEDLINE databases (2000-2024) with search terms including "lead aVR," "ST-segment elevation," "left main coronary artery," and "acute coronary syndrome." Literature review shows that STE ≥0.5 mm in aVR with diffuse ST depression has been reported to have a sensitivity of 78% and specificity of 86% for LMCA/triple-vessel disease in prior studies. However, it is important to recognize that this ECG pattern can occur in other conditions, including severe anemia, shock states, and aortic dissection. STE ≥1 mm increases diagnostic yield. Patients with this pattern have higher in-hospital mortality (8.6%-19.4% vs 1.3%) and increased heart failure and reinfarction.
interventionsA total of 2 patients underwent coronary artery bypass grafting, 2 underwent percutaneous coronary intervention, and 1 was managed medically. OUTCOMES: No in-hospital deaths occurred. LESSONS: STE in aVR with diffuse ST depression represents a high-risk ECG pattern that should prompt urgent invasive evaluation. Recognition of this high-risk ECG pattern is essential for timely diagnosis of critical LMCA stenosis and improved outcomes. However, findings from this small case series require validation in larger prospective cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.